What To Expect From USPTO On Patent Term Post-Supernus

By Matt Kamps, Dan Schwartz and Alyssa Eckerley (February 27, 2019, 3:22 PM EST) -- The U.S. Court of Appeals for the Federal Circuit recently decided Supernus Pharmaceuticals Inc. v. Iancu,[1] holding that because Supernus could not have taken "reasonable efforts to conclude prosecution" of its patent application during a 546-day period — beginning with its filing of a request for continued examination and information disclosure statement, and ending with its receipt of an EU notice of opposition and accompanying references — the U.S. Patent and Trademark Office could not treat the 546-day period as "applicant delay" under 37 C.F.R. 1.704.[2]...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!